Allianz Asset Management Gmb H Xencor Inc Transaction History

Allianz Asset Management Gmb H

  • $69.7 Billion
  • Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Xencor Inc stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 15,900 shares of XNCR stock, worth $366,813. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,900
Previous 15,900 -0.0%
Holding current value
$366,813
Previous $300,000 6.33%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$18.21 - $24.5 $289,539 - $389,550
15,900 New
15,900 $300,000
Q2 2022

Aug 12, 2022
SELL
$19.74 - $29.01 $57,976 - $85,202
-2,937 Reduced 18.97%
12,543 $343,000
Q1 2022

May 13, 2022
BUY
$26.68 - $41.63 $40,473 - $63,152
1,517 Added 10.86%
15,480 $413,000
Q4 2021

Feb 11, 2022
BUY
$33.67 - $43.44 $470,134 - $606,552
13,963 New
13,963 $560,000
Q3 2021

Nov 10, 2021
SELL
$30.65 - $35.68 $538,030 - $626,326
-17,554 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$34.33 - $44.68 $308,214 - $401,137
-8,978 Reduced 33.84%
17,554 $605,000
Q1 2021

May 13, 2021
BUY
$40.81 - $53.88 $40,687 - $53,718
997 Added 3.9%
26,532 $1.14 Million
Q4 2020

Feb 16, 2021
SELL
$36.63 - $47.63 $467,508 - $607,901
-12,763 Reduced 33.33%
25,535 $1.11 Million
Q3 2020

Nov 13, 2020
SELL
$30.09 - $43.02 $77,090 - $110,217
-2,562 Reduced 6.27%
38,298 $1.49 Million
Q2 2020

Aug 14, 2020
BUY
$27.76 - $33.42 $1.13 Million - $1.37 Million
40,860 New
40,860 $1.32 Million
Q3 2017

Nov 13, 2017
SELL
$19.61 - $23.35 $721,079 - $858,602
-36,771 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
3,514 Added 10.57%
36,771 $776,000
Q4 2016

Apr 17, 2019
BUY
N/A
33,257
33,257 $875,000

Others Institutions Holding XNCR

# of Institutions
215
Shares Held
71.8M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.38B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email